Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Novel compounds synthesized at BMS particularly useful for prevention of postsurgical adhesions

Jan. 5, 1999

Allergan reports new compounds acting as retinoid antagonists or inverse agonists

Dec. 30, 1998

Aged garlic extract: in vitro and in vivo antiallergic effects

Dec. 28, 1998

FDA accepts Hyal's NDA for Solarase

Dec. 23, 1998

Suppression of chemokine production contributes to beneficial dermal effects of tacalcitol

Dec. 22, 1998

Maxim advances development of MaxDerm topical treatment

Dec. 22, 1998

Angiotech initiates another clinical trial with paclitaxel for treatment of psoriasis

Dec. 16, 1998

Antipruritic, immunosuppressive MS-444 derivatives reported by Kyowa Hakko

Dec. 15, 1998

Thalidomide evaluated for toxic epidermal necrolysis and found detrimental

Dec. 10, 1998

Abgenix initiates a phase I/II clinical trial in patients with psoriasis

Dec. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...